FDA Recalls Mislabeled Docusate Sodium Capsules Distributed by Aidapak Services
Aidapak Services is recalling 1,998 docusate sodium capsules that may be mislabeled as 250 mg or tizanidine HCl tablets.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall involving a labeling mixup that could result in patients receiving the wrong medication or dosage, which aligns with the rubric criterion for Severe severity (FDA Class II with potential for significant harm).
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for Docusate Sodium Capsules, 100 mg, distributed by Aidapak Services, LLC. The recall involves 1,998 capsules that may be potentially mislabeled as Docusate Sodium Capsules, 250 mg, or Tizanidine HCl Tablets, 2 mg. This labeling mixup creates a risk that patients may receive the wrong medication or dosage.
The affected products were repacked and distributed in Arizona, California, Oregon, and Washington. The recall includes two specific pedigree codes: AD37063_1 with an expiration date of May 13, 2014, and W002977 with an expiration date of June 11, 2014. The FDA has classified this as a Class II recall, indicating a situation where use of, or exposure to, the product may cause temporary or medically reversible adverse health consequences.
Consumers who have these products should check their medication labels for the NDC 57896040110 and the specific pedigree codes listed above. If the product matches the description, consumers should stop using it and contact their pharmacist or healthcare provider for guidance on proper disposal or replacement.
The recalled product
- Product
- DOCUSATE SODIUM Capsule, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 57896040110
- Manufacturer
- Aidapak Services, LLC
- Affected units
- 1,998
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- DOCUSATE SODIUM
- Capsule
- 100 mg has the following codes Pedigree: AD37063_1
- EXP: 5/13/2014
- Pedigree: W002977
- EXP: 6/11/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02